Home

Biomarkers

Read time: 3 min

Congress highlights

Understanding the anhedonia across and beyond the schizophrenia

Anhedonia refers to the reduced ability to experience pleasure and happiness.1 It is one of...

Anxiety, Depression

Assessing and addressing co-morbid depression and generalised anxiety disorder

During ECNP 2022, Dr Iria Grande sat down and discussed how major depressive disorder (MDD) is...

Read time: 4 min

Congress highlights

Salivary calcitonin gene-related peptide as a potential biomarker for migraine

Levels of calcitonin gene-related peptide (CGRP) are higher in patients with migraine in the...

Bipolar, Schizophrenia

Read time: 3 min

Congress highlights

Can neuroimaging lead to the development of biomarkers in schizophrenia?

Schizophrenia presents differently in different patients, yet due to a lack of objective means to...

Parkinson's Disease

Read time: 5 min

Congress highlights

Parkinson’s disease – early detection and risk stratification

In the 200 years since James Parkinson first published his essay that gave name to the disease,1...

Read time: 6 min

Congress highlights

Highlights from the 9th Congress of the European Academy of Neurology

From 1st to 4th July 2023, nearly 8,000 neurologists from 114 countries gathered both virtually and...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country